Concord Wealth Partners Decreases Stock Position in BriaCell Therapeutics Corp. (NASDAQ:BCTX)
Concord Wealth Partners trimmed its holdings in shares of BriaCell Therapeutics Corp. (NASDAQ:BCTX – Free Report) by 29.5% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 10,775 shares of the company’s stock after selling 4,500 shares during the period. Concord Wealth Partners’ holdings […]